Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions About   Site Map   Contact Us
Home A service of the U.S. National Library of Medicine®
Printer-friendly version
MECP2-related severe neonatal encephalopathy

MECP2-related severe neonatal encephalopathy

Reviewed October 2011

What is MECP2-related severe neonatal encephalopathy?

MECP2-related severe neonatal encephalopathy is a brain disease characterized by small head size (microcephaly), poor muscle tone (hypotonia) in infancy, movement disorders, rigidity, and seizures. This condition primarily affects males. Infants with MECP2-related severe neonatal encephalopathy appear normal at birth but then develop severe brain dysfunction (encephalopathy) within the first week of life. These individuals experience poor feeding and frequent vomiting leading to a failure to gain weight and grow at the expected rate (failure to thrive). Males with MECP2-related severe neonatal encephalopathy have mild to severe intellectual disability. Affected individuals have breathing problems, with some having episodes in which breathing slows or stops for short periods (apnea). Most males with this condition do not live past the age of 2 due to respiratory failure.

How common is MECP2-related severe neonatal encephalopathy?

It is estimated that 1 in 50,000 to 100,000 males are affected with MECP2-related severe neonatal encephalopathy.

What genes are related to MECP2-related severe neonatal encephalopathy?

Mutations in the MECP2 gene cause MECP2-related severe neonatal encephalopathy. The MECP2 gene provides instructions for making a protein called MeCP2 that is critical for normal brain function. Researchers believe that this protein has several functions, including regulating other genes in the brain by switching them off when they are not needed. The MeCP2 protein likely plays a role in maintaining connections (synapses) between nerve cells. The MeCP2 protein may also control the production of different versions of certain proteins in nerve cells. Although mutations in the MECP2 gene disrupt the normal function of nerve cells, it is unclear how these mutations lead to the signs and symptoms of MECP2-related severe neonatal encephalopathy.

Read more about the MECP2 gene.

How do people inherit MECP2-related severe neonatal encephalopathy?

More than 99 percent of MECP2-related severe neonatal encephalopathy cases occur in people with no history of the disorder in their family. Many of these cases result from new mutations in the MECP2 gene.

A few families with more than one affected family member have been described. These cases helped researchers determine that MECP2-related severe neonatal encephalopathy can have an X-linked pattern of inheritance. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. One copy of the altered gene in each cell is sufficient to cause the condition. Females with these same mutations typically have a similar disorder called Rett syndrome.

Read more about Rett syndrome.

Where can I find information about diagnosis or management of MECP2-related severe neonatal encephalopathy?

These resources address the diagnosis or management of MECP2-related severe neonatal encephalopathy and may include treatment providers.

You might also find information on the diagnosis or management of MECP2-related severe neonatal encephalopathy in Educational resources and Patient support.

General information about the diagnosis and management of genetic conditions is available in the Handbook. Read more about genetic testing, particularly the difference between clinical tests and research tests.

To locate a healthcare provider, see How can I find a genetics professional in my area? in the Handbook.

Where can I find additional information about MECP2-related severe neonatal encephalopathy?

You may find the following resources about MECP2-related severe neonatal encephalopathy helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for MECP2-related severe neonatal encephalopathy?

  • severe congenital encephalopathy due to MECP2 mutation
  • severe neonatal encephalopathy due to MECP2 mutations

For more information about naming genetic conditions, see the Genetics Home Reference Condition Naming Guidelines and How are genetic conditions and genes named? in the Handbook.

What if I still have specific questions about MECP2-related severe neonatal encephalopathy?

Where can I find general information about genetic conditions?

What glossary definitions help with understanding MECP2-related severe neonatal encephalopathy?

apnea ; cell ; chromosome ; congenital ; disability ; encephalopathy ; failure to thrive ; gene ; hypotonia ; inheritance ; microcephaly ; muscle tone ; mutation ; neonatal ; pattern of inheritance ; protein ; respiratory ; sex chromosomes ; syndrome

You may find definitions for these and many other terms in the Genetics Home Reference Glossary.

See also Understanding Medical Terminology.

References (5 links)


The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? in the Handbook.

Reviewed: October 2011
Published: February 1, 2016